featured
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
N. Engl. J. Med 2021 Jul 01;385(1)46-58, E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, V Sanchorawala, S Gibbs, P Mollee, CP Venner, J Lu, S Schönland, ME Gatt, K Suzuki, K Kim, MT Cibeira, M Beksac, E Libby, J Valent, V Hungria, SW Wong, M Rosenzweig, N Bumma, A Huart, MA Dimopoulos, D Bhutani, AJ Waxman, SA Goodman, JA Zonder, S Lam, K Song, T Hansen, S Manier, W Roeloffzen, K Jamroziak, F Kwok, C Shimazaki, JS Kim, E Crusoe, T Ahmadi, N Tran, X Qin, SY Vasey, B Tromp, JM Schecter, BM Weiss, SH Zhuang, J Vermeulen, G Merlini, RL ComenzoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.